- Title
- Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group
- Creator
- Hallinan, Christine Mary; Eden, Edward; Graham, Myfanwy; Greenwood, Lisa-Marie; Mills, Jessica; Popat, Amirali; Truong, Linda; Bonomo, Yvonne
- Relation
- Journal of Psychopharmacology Vol. 36, Issue 6, p. 661-665
- Publisher Link
- http://dx.doi.org/10.1177/02698811211035394
- Publisher
- Sage
- Resource Type
- journal article
- Date
- 2021
- Description
- Amidst growing global acceptance of medicinal cannabinoids as a potential therapeutic interest in cannabidiol (CBD) is increasing. In Australia in 2020, a government inquiry examined the barriers that the public are experiencing in accessing medicinal cannabis. A number of recommendations to improve access were made. In response to these recommendations, the Australian therapeutics regulatory authority down-scheduled CBD from Prescription Only (Schedule 4) to Pharmacist Only (Schedule 3). As a group of early to mid-career researchers of the Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), we propose some considerations in relation to over-the-counter availability of CBD and opportunities to improve knowledge about its potential therapeutic benefits alongside its increased uptake.
- Subject
- medical cannabis; medicinal cannabinoids; cannabidiol; CBD; CBD down-scheduling
- Identifier
- http://hdl.handle.net/1959.13/1460617
- Identifier
- uon:46014
- Identifier
- ISSN:0269-8811
- Language
- eng
- Reviewed
- Hits: 2061
- Visitors: 2060
- Downloads: 0